Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Bharat Biotech in-licences GSK's Shigella vaccine candidate

Posted

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Please log in to like, share and comment!

Entertainment

Kangana calls Sunjay Kapur’s death ‘unbelievable and bizarre’

Sunjay Kapur, former husband of Karisma Kapoor and automotive industry leader, died at 53 in...

By 0 9

Sports

AIFF President Chaubey blasts Baichung Bhutia: 'If there was any corruption ... '

As the Indian footballing landscape navigates a period of turmoil, AIFF President Kalyan Chaubey...

By 0 10

International

'Expect several waves of Iranian attacks': Netanyahu after Israeli strikes; US moves destroyers to region

Israeli Prime Minister Benjamin Netanyahu announced a strike on Iranian military and nuclear...

By 0 15

Business

Israel-Iran tensions: India has adequate energy supplies, says Union minister Puri amid rising crude prices; citing energy strategy trilemma

Following the recent surge in global crude prices due to escalating tensions in the Middle East,...

By 0 19

Business

Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman

Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September...

By 0 19